3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
13
Terminated
5
Active not recruiting
5
Withdrawn
1
Unknown
1
Suspended
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Lymphoma
25
Small Cell Lung Carcinoma
23
Leukemia
18
Lymphoma, Large B-Cell, Diffuse
17
Lung Neoplasms
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma, Non-Hodgkin
14
Lymphoma, Extranodal NK-T-Cell
11
Hodgkin Disease
10
Leukemia, Myeloid, Acute
8
Carcinoma, Non-Small-Cell Lung
8
Ovarian Neoplasms
7
Neuroblastoma
7
Lymphoma, Mantle-Cell
7
Burkitt Lymphoma
7
Recurrence
6
Lymphoma, T-Cell, Peripheral
6
Central Nervous System Neoplasms
6
Retinoblastoma
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphohistiocytosis, Hemophagocytic
5
Breast Neoplasms
5
Testicular Neoplasms
4
Multiple Myeloma
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Teratoma
3
Interventions
Exercise
18
Drug Therapy
17
pembrolizumab
12
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Dexamethasone
9
Paclitaxel
8
Standard of Care
7
Oxaliplatin
7
Nivolumab
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Control Groups
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Etoposide
×
Clear all
NCT02015728
2016-12-15
SEED
Seattle Children's Hospital
Phase NA
Unknown
20 enrolled